Pronađeno: 31-40 / 341 radova

Autori: Damjanov Nemanja S

>> Filter: Samo Article i Review

>> Sve godine

Naslov Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (Meeting Abstract)
Autori Rech Juergen ... Damjanov Nemanja S ... (broj koautora 25) 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study (Meeting Abstract)
Autori Strand Vibeke Mease Philip Soriano Enrique Kishimoto Mitsumasa Salvarani Carlo Damjanov Nemanja S Anderson Jaclyn K Blondell Erin Zueger Patrick Saffore Christopher Gladman Dafna 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Projekat AbbVie
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks (Meeting Abstract)
Autori Smolen Josef S Emery Paul Rigby William Tanaka Yoshiya Vargas Juan Damjanov Nemanja S Jain Manish Song Yanna Khan Nasser Enejosa Jeffrey Cohen Stanley B 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries (Article)
Autori Meisters Rachelle ... Damjanov Nemanja S ... (broj koautora 46) 
Info ANNALS OF THE RHEUMATIC DISEASES, (2020), vol. 79 br. 11, str. 1423-1431
Projekat NIHR Manchester Biomedical Research CentreNational Institute for Health Research (NIHR); Versus ArthritisVersus Arthritis [20380]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov The Relationship Between Tc-99m-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study (Article)
Autori Pavlov-Dolijanovic Slavica R  Petrovic Nebojsa S Vujasinovic-Stupar Nada Z Damjanov Nemanja S Radunovic Goran L  Babic Dragan D Sobic-Saranovic Dragana P Artiko Vera M 
Info ARCHIVES OF RHEUMATOLOGY, (2020), vol. 35 br. 3, str. 321-327
Projekat Ministry of Education, Science and Technological Development of Serbia [M175018]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article)
Autori Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N  Radunovic Goran L  Kivitz Alan J Cox Lori Manukyan Zorayr Banfield Christopher Saunders Michael Chandra Deepa Vincent Michael S Mancuso Jessica Peeva Elena Beebe Jean S 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631
Projekat Pfizer, Inc.Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article)
Autori Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N  Radunovic Goran L  Kivitz Alan J Cox Lori Manukyan Zorayr Banfield Christopher Saunders Michael Chandra Deepa Vincent Michael S Mancuso Jessica Peeva Elena Beebe Jean S 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631
Projekat Pfizer, Inc.Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrial (Article)
Autori Cohen Stanley B ... Damjanov Nemanja S ... (broj koautora 18) 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 9, str. 1435-1446
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management (Editorial Material)
Autori Matucci-Cerinic Marco ... Damjanov Nemanja S ... (broj koautora 20) 
Info ANNALS OF THE RHEUMATIC DISEASES, (2020), vol. 79 br. 6, str. 724-726
Projekat Actelion; CSL Behring; Eli Lilly; Inventiva; Roche Holding; Sanofi; Abbvie; Celltrion; Sanofi-Genzyme; SOBI; Kline; Corbus, Acceleron; Competitive Drug Development International Ltd; Ergonex; Bayer AG; Boehringe
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (Article)
Autori Gossec Laure ... Damjanov Nemanja S ... (broj koautora 28) 
Info ANNALS OF THE RHEUMATIC DISEASES, (2020), vol. 79 br. 6, str. 700-712
Projekat European League Against Rheumatism; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (LBRC)National Institute for Health Research (NIHR)
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX